Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

bluebird bio Stock Signals Potential to be a Multi-bagger: https://www.marketbeat.com/logos/articles/med_20240229085127_bluebird-bio-stock-signals-potential-to-be-a-multi.jpg
bluebird bio Stock Signals Potential to be a Multi-bagger

It isn’t often that you can find the right story at the right time to give you a good chance of multiplying your wealth; these so-called multi-bagger stocks get their name because their price sees

Wendy's Walks Back Surge Pricing Talk After Social Media Grilling: https://www.marketbeat.com/logos/articles/med_20240229082934_wendys-walks-back-surge-pricing-talk-after-social.jpg
Wendy's Walks Back Surge Pricing Talk After Social Media Grilling

Wendy’s Company (NASDAQ: WEN) stock traded nearly 2% higher on February 28 as the fast-food mid-cap said it would not raise prices at times of high demand. 

The turnaround came after Wendy’s CEO

CarGurus Stock is Set for a Rally This Quarter, Above all Peers: https://www.marketbeat.com/logos/articles/med_20240228081944_cargurus-stock-is-set-for-a-rally-this-quarter-abo.jpg
CarGurus Stock is Set for a Rally This Quarter, Above all Peers

Some businesses could soon see the bullish side effects of a resilient consumer amongst the pretext of potential interest rate cuts coming this year from the FED. According to the FedWatch tool at

How to Use Credit Spreads to Make Income from Options: https://www.marketbeat.com/logos/articles/med_20240227115611_option-cs-intc.jpg
How to Use Credit Spreads to Make Income from Options

If you are bullish on any optionable stock in any stock sector, you can play any number of options trades. The easiest directional strategy is to buy a call option. However, you will fight time

Insider selling at JPM: A Closer Look Amidst Historic CEO Sale: https://www.marketbeat.com/logos/articles/med_20240228071044_insider-selling-at-jpm-a-closer-look-amidst-histor.jpg
Insider selling at JPM: A Closer Look Amidst Historic CEO Sale

The recent insider selling activity at JPMorgan Chase & Co. (NYSE: JPM), a leading banking and financial institution, has drawn notable attention, with CEO Jamie Dimon making his first-ever stock

Workday Stock Price is Working on a Buy-the-Dip Opportunity: https://www.marketbeat.com/logos/articles/med_20240227131949_chart-wday-2272024ver001.png
Workday Stock Price is Working on a Buy-the-Dip Opportunity

Workday, Inc. (NASDAQ: WDAY) issued a lackluster FQ2 report that left the market wishing for more. However, as tepid as the results are, underperformance is relative to analysts' consensus

3 wealth-compounding stocks to beat the market this decade: https://www.marketbeat.com/logos/articles/med_20240226123613_3-wealth-compounding-stocks-to-beat-the-market-thi.jpg
3 wealth-compounding stocks to beat the market this decade

Because the Federal Reserve (the Fed) has announced potential interest rate cuts for this year, an expectation priced in for March is now being pushed as far back as May or June, according to the 

Palantir Stock Has It all… Except the Analysts' Support: https://www.marketbeat.com/logos/articles/med_20240227195033_palantir-stock-has-it-all-except-the-analysts-supp.jpg
Palantir Stock Has It all… Except the Analysts' Support

Palantir Technologies (NYSE: PLTR) stock is gaining traction and may advance another 50% or more in the next few months. The company has a solid product, growing demand, deepening penetration and

Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73761/AC_Vidac_280224.001.png
Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. 525% Biotech Hot Stock nach 9.290% mit Novo-Nordisk

 

28.02.24 08:03

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Autozone stock price is still in the rally zone: https://www.marketbeat.com/logos/articles/med_20240227110105_chart-azo-22272024ver001.png
Autozone stock price is still in the rally zone

Autozone (NYSE: AZO) shares surged following the FQ2 report, confirming the uptrend is intact. Because the news aligns with the outlook for growth and capital returns, the trend will likely

Westward Gold Outlines 2024 Exploration Goals at Cortez Trend Properties: https://www.irw-press.at/prcom/images/messages/2024/73753/Westward_022724_ENPRcom.002.png
Westward Gold Outlines 2024 Exploration Goals at Cortez Trend Properties

Vancouver, British Columbia, February 27, 2024 – Westward Gold Inc. (CSE: WG, OTCQB: WGLIF, FSE: IM50) (“Westward” or the “Company”) is pleased to provide preliminary details surrounding

New highs are coming for Lowe’s stock despite mixed results: https://www.marketbeat.com/logos/articles/med_20240227090542_chart-low-2272024ver001.png
New highs are coming for Lowe’s stock despite mixed results

At face value, Lowe’s Companies (NYSE: LOW) had a rough Q4 compared to competitor Home Depot, but the details within the report belie that assessment. Comps were weak, but the company is building

3 lithium stocks to ride a multi-year cycle: https://www.marketbeat.com/logos/articles/med_20240227091730_3-lithium-stocks-to-ride-a-multi-year-cycle.jpg
3 lithium stocks to ride a multi-year cycle

The world used to run on coal and other types of fuel that powered the different titans of industry. This cycle started with transportation through railways to factories and steel mills that were

Goldman upgraded Nvidia stock, one metric says it could go higher: https://www.marketbeat.com/logos/articles/med_20240227091342_goldman-upgraded-nvidia-stock-one-metric-says-it-c.jpg
Goldman upgraded Nvidia stock, one metric says it could go higher

Today's market seems to be all over the hype stories found in the world of technology stocks. This is especially the case with blowout performances by names like Nvidia Corporation (NASDAQ: NVDA)

bluebird bio: How to play LEAPS options for growth and income: https://www.marketbeat.com/logos/articles/med_20240226111048_option-blue-stock.jpg
bluebird bio: How to play LEAPS options for growth and income

Gene-editing is making huge headlines in the medical sector stemming from the first FDA approval for a CRISPR/cas9 treatment for sickle cell disease SCD and TDT from CRISPR Therapeutics AG

Thinking long-term? Don't lose interest in Pinterest: https://www.marketbeat.com/logos/articles/med_20240226120753_thinking-long-term-dont-lose-interest-in-pinterest.jpg
Thinking long-term? Don't lose interest in Pinterest

Pinterest Inc. (NYSE: PINS) stock suffered a 12% sell-off on its Q4 2023 earnings report. The main reason for the selling was a miss on the top line, as revenues failed to beat consensus analyst

Salesforce stock got a boost. Is it growing off the Nvidia boom?: https://www.marketbeat.com/logos/articles/med_20240226114104_salesforce-stock-got-a-boost.jpg
Salesforce stock got a boost. Is it growing off the Nvidia boom?

Most hype surrounds technology stocks, particularly after the king of the sector, Nvidia Corp. (NASDAQ: NVDA), kept breaking past all-time high prices on ever-increasing financial expansion. There

Eilt: Durchbruch in der Krebsforschung - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73736/aktiencheck27022401.001.png
Eilt: Durchbruch in der Krebsforschung - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Durchbruch in der Krebsforschung - 100 mal wirksamer gegen Krebs. 525% Biotech Aktientip nach 15.973% mit BioNTech

 

27.02.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Is The Trade Desk signaling the rebound of digital advertising?: https://www.marketbeat.com/logos/articles/med_20240225154933_chartz-ttd.jpg
Is The Trade Desk signaling the rebound of digital advertising?

The Trade Desk Inc. (NASDAQ: TTD) is a leading independent programmatic advertising technology (AdTech) platform provider. Its demand-side platform (DSP) allows companies to automate their digital

Domino’s stock or Papa John’s? Follow price action to find out: https://www.marketbeat.com/logos/articles/med_20240226091810_dominos-stock-or-papa-johns-follow-price-action-to.jpg
Domino’s stock or Papa John’s? Follow price action to find out

Most of the market is now focused on the hype in the high-flying technology stocks today, where names like NVIDIA (NASDAQ: NVDA) keep delivering insane financial results to help the stock break

Is CRISPR Therapeutics the NVIDIA of gene editing?: https://www.marketbeat.com/logos/articles/med_20240225160343_chart-crsp.jpg
Is CRISPR Therapeutics the NVIDIA of gene editing?

CRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approval for a gene-editing therapy for

Block's multiple ecosystems drive shares higher on 2024 outlook: https://www.marketbeat.com/logos/articles/med_20240225155825_charts-sq.jpg
Block's multiple ecosystems drive shares higher on 2024 outlook

Block Inc. (NYSE: SQ) is a technology company with multiple ecosystems generating a network and cumulative effect. It's most known as a fintech operating its Square segment, which is a digital and

6 reasons to buy Teva Pharmaceuticals stock sooner than later: https://www.marketbeat.com/logos/articles/med_20240225160005_chartm-teva.jpg
6 reasons to buy Teva Pharmaceuticals stock sooner than later

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a global pharmaceutical company in the medical sector specializing in generic and specialty medications. The company has been suffering under

Analysts boosted Snowflake stock, big firms are buying now: https://www.marketbeat.com/logos/articles/med_20240225194338_analysts-boosted-snowflake-stock-big-firms-are-buy.jpg
Analysts boosted Snowflake stock, big firms are buying now

All the market hype is now focusing on the world of technology stocks, especially after the massive run-up in names like Nvidia Corporation (NASDAQ: NVDA) and other companies involved with the